Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Keros halts blood pressure treatment trial on safety issues
Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to ...
I'm a cardiologist and this breakfast is perfect for optimal arterial health
Arterial health is essential for overall well-being and the prevention of cardiovascular disease. Dr. Michael Twyman, a ...
Pulmonaryhypertensionnews.com1d
Right heart size differs between men and women with PAH: Study
Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...
Taking blood pressure in noisy settings doesn't affect reading, study shows
A new study found a minor difference between blood pressure measurements taken in public spaces compared to those in private ...
Hypertension: Understanding and managing high blood pressure
The human body contains over 70,000 miles of blood vessels, lined by a single layer of endothelial cells. This inner lining, ...
Endocrinology Advisor13d
Oxygen Delivery, Consumption Increased With Higher Mean Arterial BP Target
Targeting a MAP of 77 mm Hg in patients comatose following resuscitation from out-of-hospital cardiac arrest improves oxygenation outcomes.
Rolling Out10d
How a brain aneurysm forms
A brain aneurysm develops when a blood vessel wall weakens, creating a balloon-like bulge that can threaten life if ruptured.
Daily6d
Novel PET approach may identify early signs of pulmonary arterial hypertension, highlights research
A new molecular imaging technique-18F-FAPI PET-can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker ...